2017 | 03 | 30

Vironova is building a state of the art electron microscopy (EM) facility to meet increasing demand

Vironova has established a growing number of global customers in the highly-regulated and quality demanding pharmaceutical industry, who focus on drug/gene delivery and vaccine development. Currently 7 of the 10 largest biopharmaceutical companies are clients to Vironova.

The new EM facility with a BSLII laboratory for sample preparation will greatly increase current capacity and meet the increasing demand for nanoparticle characterization services that the company provides. These are performed using TEM and the proprietary image analysis software VAS (Vironova Analyzer Software) in accordance with GMP, which is essential for applications in pharmaceutical development. Several Microscopists are being recruited for the new lab, which will be finalized during this year.

News and events

Read about the latest news and events at Vironova.

  • All news
  • Inside Vironova
  • Open positions
  • Events and publications
VIEW MORE
VIEW MORE
VIEW MORE
VIEW MORE

Upcoming events 2017

Bioprocess International & Cell and gene therapy bioprocessing
September 25-28 in Boston

  • Exhibition of MiniTEM
  • Technology workshop Tuesday September 26, at 11:50am - 12:20pm
  • Title: Meaningful insights on sub-visible particle morphology, size and purity
  • Speaker: Mathieu Colomb-Delsuc, Senior Scientist

Upcoming webinar October 18

  • Title: MiniTEM Analysis of Viral Vector Particles Provides Insight in Shorter Turnaround Time as Compared to Traditional Assays
  • Speaker: Josefina Nilsson, head of EM services
  • Register here

Vironova on MyNewsDesk

Follow us on MyNewsDesk and get the latest info on investor relations, events and company news.
Click here to get to our MyNewsDesk-page.

Press contact
For press enquiries, please contact
info@vironova.com

IR contact
Mohammed Homman
ceo@vironova.com